scholarly journals Secondary aortic valve replacement in continuous flow left ventricular assist device therapy

2021 ◽  
Author(s):  
Takayuki Gyoten ◽  
Michiel Morshuis ◽  
Henrik Fox ◽  
Marcus‐André Deutsch ◽  
Hakim‐Meibodi Kavous ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Continuous Flow ◽  
Left Ventricular ◽  
Device Therapy ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist

Effects of Continuous-Flow Left Ventricular Assist Device Therapy on Peripheral Vascular Function

ASAIO Journal ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Ersin Kaya ◽  
Umut Kocabas ◽  
Evrim Simsek ◽  
Sanem Nalbantgil ◽  
Umit Kahraman ◽  
...  
Keyword(s):  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Vascular Function ◽  
Continuous Flow ◽  
Left Ventricular ◽  
Peripheral Vascular ◽  
Device Therapy ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist

Concomitant Valve-In-Valve Transcatheter Aortic Valve Replacement and Left Ventricular Assist Device Implantation

2017 ◽  
Vol 12 (2) ◽  
pp. 147-149 ◽  
Author(s):  
Takashi Murashita ◽  
David L. Joyce ◽  
Alberto Pochettino ◽  
John M. Stulak ◽  
Lyle D. Joyce
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Prosthetic Valve ◽  
Left Ventricular ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist ◽  
Valve In Valve

Redo aortic valve replacement (AVR) performed simultaneously with left ventricular assist device (LVAD) implantation carries potential for increased mortality rates. Although transcatheter AVR has been used for patients with previous LVAD placement, no literature reports concomitant valve-in-valve transcatheter AVR and LVAD implantation. Our patient had severe aortic prosthetic valve deterioration and advanced heart failure. Given the risks associated with reoperative aortic valve surgery, we chose transcatheter AVR at the time of LVAD implantation. Transthoracic echocardiography results showed severe aortic prosthetic valve deterioration with moderate aortic regurgitation as well as severe left ventricular dysfunction (ejection fraction, 11%). After redosternotomy, we performed transcatheter AVR via the ascending aorta and subsequent LVAD implantation. The postoperative course was uneventful. Generally, patients with structural deterioration of a bioprosthetic valve who report for LVAD therapy present considerable challenges to the surgeon. Concomitant transcatheter AVR offers a less-invasive alternative to surgical AVR that minimizes ischemic injury to myocardium.

Sign in / Sign up

Export Citation Format

Share Document